![Submicron particle docetaxel intratumoral injection in combination with anti-mCTLA-4 into 4T1-Luc orthotopic implants reduces primary tumor and metastatic pulmonary lesions | SpringerLink Submicron particle docetaxel intratumoral injection in combination with anti-mCTLA-4 into 4T1-Luc orthotopic implants reduces primary tumor and metastatic pulmonary lesions | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs12032-021-01555-1/MediaObjects/12032_2021_1555_Fig1_HTML.png)
Submicron particle docetaxel intratumoral injection in combination with anti-mCTLA-4 into 4T1-Luc orthotopic implants reduces primary tumor and metastatic pulmonary lesions | SpringerLink
![Submicron particle docetaxel intratumoral injection in combination with anti-mCTLA-4 into 4T1-Luc orthotopic implants reduces primary tumor and metastatic pulmonary lesions | SpringerLink Submicron particle docetaxel intratumoral injection in combination with anti-mCTLA-4 into 4T1-Luc orthotopic implants reduces primary tumor and metastatic pulmonary lesions | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs12032-021-01555-1/MediaObjects/12032_2021_1555_Fig4_HTML.png)
Submicron particle docetaxel intratumoral injection in combination with anti-mCTLA-4 into 4T1-Luc orthotopic implants reduces primary tumor and metastatic pulmonary lesions | SpringerLink
![Submicron particle docetaxel intratumoral injection in combination with anti-mCTLA-4 into 4T1-Luc orthotopic implants reduces primary tumor and metastatic pulmonary lesions | SpringerLink Submicron particle docetaxel intratumoral injection in combination with anti-mCTLA-4 into 4T1-Luc orthotopic implants reduces primary tumor and metastatic pulmonary lesions | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs12032-021-01555-1/MediaObjects/12032_2021_1555_Fig5_HTML.png)
Submicron particle docetaxel intratumoral injection in combination with anti-mCTLA-4 into 4T1-Luc orthotopic implants reduces primary tumor and metastatic pulmonary lesions | SpringerLink
![Submicron particle docetaxel intratumoral injection in combination with anti-mCTLA-4 into 4T1-Luc orthotopic implants reduces primary tumor and metastatic pulmonary lesions | SpringerLink Submicron particle docetaxel intratumoral injection in combination with anti-mCTLA-4 into 4T1-Luc orthotopic implants reduces primary tumor and metastatic pulmonary lesions | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs12032-021-01555-1/MediaObjects/12032_2021_1555_Fig6_HTML.png)